[go: up one dir, main page]

ES2115067T3 - Composiciones y metodos para el tratamiento de enfermedades de autoinmunidad. - Google Patents

Composiciones y metodos para el tratamiento de enfermedades de autoinmunidad.

Info

Publication number
ES2115067T3
ES2115067T3 ES93916485T ES93916485T ES2115067T3 ES 2115067 T3 ES2115067 T3 ES 2115067T3 ES 93916485 T ES93916485 T ES 93916485T ES 93916485 T ES93916485 T ES 93916485T ES 2115067 T3 ES2115067 T3 ES 2115067T3
Authority
ES
Spain
Prior art keywords
methods
utilities
compositions
self
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916485T
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2115067T3 publication Critical patent/ES2115067T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A METODOS PARA TRATAR ENFERMEDADES AUTOINMUNES ADMINISTRANDO A UN HUESPED AFLIGIDO COMPOSICIONES FARMACEUTICAS QUE CONTIENEN UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE UNA COMBINACION DE (A) Y (B) EN UNA RELACION DE PESO QUE VA DE APROXIMADAMENTE 1:1 A APROXIMADAMENTE 1:10 (A:B); DONDE R ES OH, NH2, OW, O H; X ES H, F, C1 BR, I, OH, OW, NO2 O NH2; Y ES H, F, C1, BR, O I; W ES (1) O UN GRUPO ALIFATICO C1-C12; Z ES UN GRUPO AROMATICO O ALIFATICO DE C1-C12; X E Y PUEDEN AMBOS VARIAR DENTRO DEL COMPUESTO; O SALES FARMACEUTICAMENTE ACEPTABLES DE ESTOS. SE DESCRIBE PARTICULARMENTE UNA COMPOSICION QUE COMPRENDE UNA RELACION DE 1 A 4 DE SALES DE SODIO DE FENILACETILGLUTAMINA Y ACIDO FENILACETICO, FORMULADAS TANTO EN FORMA PARENTERAL COMO ORAL CLINICAMENTE UTILES EN EL TRATAMIENTO DE ARTRITIS REUMATOIDE, LUPUS ERYTHEMATOSUS, VASCULITIS, DIABETES MELLITUS INSULINODEPENDIENTE, ESCLEROSIS MULTIPLE.
ES93916485T 1992-06-15 1993-06-10 Composiciones y metodos para el tratamiento de enfermedades de autoinmunidad. Expired - Lifetime ES2115067T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/898,295 US5646182A (en) 1992-06-15 1992-06-15 Methods for treating autoimmune diseases

Publications (1)

Publication Number Publication Date
ES2115067T3 true ES2115067T3 (es) 1998-06-16

Family

ID=25409238

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916485T Expired - Lifetime ES2115067T3 (es) 1992-06-15 1993-06-10 Composiciones y metodos para el tratamiento de enfermedades de autoinmunidad.

Country Status (10)

Country Link
US (1) US5646182A (es)
EP (1) EP0603383B1 (es)
AT (1) ATE162714T1 (es)
AU (1) AU656484B2 (es)
DE (1) DE69316729T2 (es)
DK (1) DK0603383T3 (es)
ES (1) ES2115067T3 (es)
GR (1) GR3026681T3 (es)
SG (1) SG81891A1 (es)
WO (1) WO1993025201A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
SE521031C2 (sv) * 1999-05-05 2003-09-23 Srinivas Uppugunduri Nya specifika inhibitorer av akut och kronisk inflammation
EP1642885B1 (en) 2000-08-29 2009-11-11 Biocon Limited Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
EP1890767A2 (en) * 2005-05-27 2008-02-27 Pfizer Products Inc. Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522212A (en) * 1975-04-30 1978-08-23 Science Union & Cie Glutamine derivatives process for their preparation and pharmaceutical compositions containing them
JPS53113032A (en) * 1977-03-09 1978-10-03 Mitsubishi Chem Ind Ltd Immune depresants
US4438029A (en) * 1978-01-19 1984-03-20 Research Corporation Synthetic peptides
JPS54160740A (en) * 1978-06-09 1979-12-19 Takeda Chem Ind Ltd Anti-fibrotic agent
EP0052296B1 (en) * 1980-11-12 1984-06-27 Mitsubishi Kasei Corporation Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US5098906A (en) * 1983-10-31 1992-03-24 Warner-Lambert Company Purine derivatives
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US5039704A (en) * 1985-09-12 1991-08-13 Brigham And Women's Hospital Method of treating catabolic dysfunction
ATE54826T1 (de) * 1985-10-23 1990-08-15 Mulli Kurt Nachf Gmbh Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
US4914112A (en) * 1986-06-03 1990-04-03 Sumitomo Pharmaceuticals Company, Limited Aminoazole derivatives and their production and use
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
US5244922A (en) * 1990-09-04 1993-09-14 Burzynski Stanislaw R Methods for treating viral infections
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease

Also Published As

Publication number Publication date
SG81891A1 (en) 2001-07-24
EP0603383B1 (en) 1998-01-28
EP0603383A1 (en) 1994-06-29
DE69316729T2 (de) 1998-08-06
ATE162714T1 (de) 1998-02-15
EP0603383A4 (en) 1994-12-21
AU4631993A (en) 1994-01-04
WO1993025201A1 (en) 1993-12-23
AU656484B2 (en) 1995-02-02
DE69316729D1 (de) 1998-03-05
GR3026681T3 (en) 1998-07-31
DK0603383T3 (da) 1998-09-21
US5646182A (en) 1997-07-08

Similar Documents

Publication Publication Date Title
ES2120608T3 (es) Composicion y metodo mejorados para despejar suelos.
PE20050130A1 (es) Compuestos organicos
AR013726A1 (es) Compuesto de aminoacido ciclico, composicion farmaceutica que lo comprendey su uso para preparar dicha composicion farmaceutica
PT93502A (pt) Processo para a preparacao de novos derivados de insulina e de composicoes farmaceuticas que os contem
KR970059163A (ko) 할로겐기가 치환된 2-페닐-1, 2-에탄디올 카바메이트 화합물
UY28280A1 (es) 2- hidroxi - 3- diaminoalcanos de benzamida
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
MX9305621A (es) (s)-(+)-hidroxicloroquina.
MX173274B (es) Metodos y composiciones biocidas para sistemas de agua recirculante
AR062931A2 (es) Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
EP0911331A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ES2142873T3 (es) Metodo para tratar infecciones virales.
RU2008142527A (ru) Производные бупренорфина и их применение
ES2115067T3 (es) Composiciones y metodos para el tratamiento de enfermedades de autoinmunidad.
BR9902995A (pt) Composição, uso da mesma, e, processo para inibir a formação de incrustação em um sistema de produção de hidrocarbonetos
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
MX9307475A (es) Monofilamentos antimicrobianos para cepillos de dientes.
IT1275997B1 (it) Enammine come accelleranti di vulcanizzazione per gomme naturali o sintetiche
AR041954A1 (es) Un proceso para preparar acetato de risperidona y compuestos intermediarios para dicho proceso
MX9400038A (es) Composiciones y metodos para proveer un efecto analgesico mejorado.
AR019664A1 (es) Composicion para el tratamiento de enfermedades del cartilago
PE20000262A1 (es) Composiciones para la prevencion y tratamiento del resfriado y sintomas similares a la gripe asociados con infecciones del sistema respiratorio y su metodo de uso
TW200516345A (en) Dissolution inhibitors in photoresist compositions for microlithography
KR930703013A (ko) 항당뇨병제로서 유용한 신규한 글루코하이드롤라제 억제제
GR3019970T3 (en) Pharmaceutical compositions for use in treating aids

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 603383

Country of ref document: ES